Not
FDIC
or
NCUA
Insured
No
Financial
Institution
Guarantee
May
Lose
Value
STRATEGIC
BETA
ETFs
Semiannual
Report
April
30,
2023
(Unaudited)
Columbia
Research
Enhanced
Core
ETF
Columbia
Research
Enhanced
Value
ETF
Strategic
Beta
ETFs
|
Semiannual
Report
2023
TABLE
OF
CONTENTS
Columbia
Research
Enhanced
Core
ETF
Fund
at
a
Glance
3
Columbia
Research
Enhanced
Value
ETF
Fund
at
a
Glance
5
Understanding
Your
Fund’s
Expenses
7
Portfolio
of
Investments
8
Statement
of
Assets
and
Liabilities
20
Statement
of
Operations
21
Statement
of
Changes
in
Net
Assets
22
Financial
Highlights
23
Notes
to
Financial
Statements
25
Liquidity
Risk
Management
Program
32
Additional
Information
33
FUND
AT
A
GLANCE
Columbia
Research
Enhanced
Core
ETF
(Unaudited)
Strategic
Beta
ETFs
|
Semiannual
Report
2023
3
Portfolio
management
Christopher
Lo,
CFA
Lead
Portfolio
Manager
Managed
Fund
since
2019
Jason
Wang,
CFA
Portfolio
Manager
Managed
Fund
since
2019
Investment
objective
Columbia
Research
Enhanced
Core
ETF
(the
Fund)
seeks
investment
results
that,
before
fees
and
expenses,
closely
correspond
to
the
performance
of
the
Beta
Advantage
®
Research
Enhanced
U.S.
Equity
Index.
All
results
shown
assume
reinvestment
of
distributions
during
the
period.
Returns
do
not
reflect
the
deduction
of
taxes
that
a
shareholder
may
pay
on
Fund
distributions
or
on
the
redemption
of
Fund
shares.
Performance
results
reflect
the
effect
of
any
fee
waivers
or
reimbursements
of
Fund
expenses
by
Columbia
Management
Investment
Advisers,
LLC
and/or
any
of
its
affiliates.
Absent
these
fee
waivers
or
expense
reimbursement
arrangements,
performance
results
would
have
been
lower.
The
performance
information
shown
represents
past
performance
and
is
not
a
guarantee
of
future
results.
The
investment
return
and
principal
value
of
your
investment
will
fluctuate
so
that
your
shares,
when
redeemed,
may
be
worth
more
or
less
than
their
original
cost.
Current
performance
may
be
lower
or
higher
than
the
performance
information
shown.
You
may
obtain
performance
information
current
to
the
most
recent
month-end
by
visiting
columbiathreadneedleus.com/etfs.
Through
July
31,
2020,
Market
Price
returns
are
based
on
the
midpoint
of
the
bid/ask
spread
for
Fund
shares
at
market
close
(typically
4
pm
ET).
Beginning
with
August
31,
2020
month-end
performance,
Market
Price
returns
are
based
on
closing
prices
reported
by
the
Fund's
primary
listing
exchange
(typically
4
pm
ET
close).
These
returns
do
not
represent
the
returns
an
investor
would
receive
if
shares
were
traded
at
other
times.
The
Fund’s
shares
may
trade
above
or
below
their
net
asset
value.
The
net
asset
value
of
the
Fund
will
generally
fluctuate
with
changes
in
the
market
value
of
the
Fund’s
holdings.
The
market
prices
of
shares,
however,
will
generally
fluctuate
in
accordance
with
changes
in
net
asset
value
as
well
as
the
relative
supply
of,
and
demand
for,
shares
on
the
exchange.
The
trading
price
of
shares
may
deviate
significantly
from
the
net
asset
value.
The
Beta
Advantage
®
Research
Enhanced
U.S.
Equity
Index
aims
to
achieve
stronger
total
return
than
the
Russell
1000®
Index
through
a
rules-based
strategic
beta
approach.
The
Index
methodology
leverages
the
results
of
Columbia
Threadneedle
Investment’s
proprietary
quantitative
investment
models
to
rate
each
company
within
the
Russell
1000®
Index
based
on
quality,
value
and
catalyst
factors,
and
selects
securities
that
are
favorably
rated.
It
is
market
cap-weighted
and
sector-neutral
to
the
Russell
1000®
Index.
The
Russell
1000®
Index
tracks
the
performance
of
1,000
of
the
largest
U.S.
companies,
based
on
market
capitalization.
Indices
are
not
available
for
investment,
are
not
professionally
managed
and
do
not
reflect
sales
charges,
fees,
brokerage
commissions,
taxes
or
other
expenses
of
investing.
Securities
in
the
Fund
may
not
match
those
in
an
index.
Average
annual
total
returns
(%)
(for
period
ended
April
30,
2023)
Inception
6
Months
cumulative
1
Year
Life
Market
Price
09/25/19
8.24
2.92
13.05
Net
Asset
Value
09/25/19
8.26
2.72
12.96
{
Beta
Advantage®
}
Research
Enhanced
U.S.
Equity
Index
8.35
2.89
13.20
Russell
1000®
Index
8.01
1.82
11.34
FUND
AT
A
GLANCE
(continued)
Columbia
Research
Enhanced
Core
ETF
(Unaudited)
4
Strategic
Beta
ETFs
|
Semiannual
Report
2023
Equity
sector
breakdown
(%)
(at
April
30,
2023)
Information
Technology
25
.1
Health
Care
13
.5
Financials
13
.3
Consumer
Discretionary
9
.7
Industrials
9
.3
Communication
Services
8
.6
Consumer
Staples
7
.2
Energy
4
.9
Materials
2
.8
Utilities
2
.8
Real
Estate
2
.8
Total
100
.0
Percentages
indicated
are
based
upon
total
equity
investments.
The
Fund’s
portfolio
composition
is
subject
to
change.
FUND
AT
A
GLANCE
Columbia
Research
Enhanced
Value
ETF
(Unaudited)
Strategic
Beta
ETFs
|
Semiannual
Report
2023
5
Portfolio
management
Christopher
Lo,
CFA
Lead
Portfolio
Manager
Managed
Fund
since
2019
Jason
Wang,
CFA
Portfolio
Manager
Managed
Fund
since
2019
Investment
objective
Columbia
Research
Enhanced
Value
ETF
(the
Fund)
seeks
investment
results
that,
before
fees
and
expenses,
closely
correspond
to
the
performance
of
the
Beta
Advantage
®
Research
Enhanced
U.S.
Value
Index.
All
results
shown
assume
reinvestment
of
distributions
during
the
period.
Returns
do
not
reflect
the
deduction
of
taxes
that
a
shareholder
may
pay
on
Fund
distributions
or
on
the
redemption
of
Fund
shares.
Performance
results
reflect
the
effect
of
any
fee
waivers
or
reimbursements
of
Fund
expenses
by
Columbia
Management
Investment
Advisers,
LLC
and/or
any
of
its
affiliates.
Absent
these
fee
waivers
or
expense
reimbursement
arrangements,
performance
results
would
have
been
lower.
The
performance
information
shown
represents
past
performance
and
is
not
a
guarantee
of
future
results.
The
investment
return
and
principal
value
of
your
investment
will
fluctuate
so
that
your
shares,
when
redeemed,
may
be
worth
more
or
less
than
their
original
cost.
Current
performance
may
be
lower
or
higher
than
the
performance
information
shown.
You
may
obtain
performance
information
current
to
the
most
recent
month-end
by
visiting
columbiathreadneedleus.com/etfs.
Through
July
31,
2020,
Market
Price
returns
are
based
on
the
midpoint
of
the
bid/ask
spread
for
Fund
shares
at
market
close
(typically
4
pm
ET).
Beginning
with
August
31,
2020
month-end
performance,
Market
Price
returns
are
based
on
closing
prices
reported
by
the
Fund's
primary
listing
exchange
(typically
4
pm
ET
close).
These
returns
do
not
represent
the
returns
an
investor
would
receive
if
shares
were
traded
at
other
times.
The
Fund’s
shares
may
trade
above
or
below
their
net
asset
value.
The
net
asset
value
of
the
Fund
will
generally
fluctuate
with
changes
in
the
market
value
of
the
Fund’s
holdings.
The
market
prices
of
shares,
however,
will
generally
fluctuate
in
accordance
with
changes
in
net
asset
value
as
well
as
the
relative
supply
of,
and
demand
for,
shares
on
the
exchange.
The
trading
price
of
shares
may
deviate
significantly
from
the
net
asset
value.
The
Beta
Advantage
®
Research
Enhanced
U.S.
Value
Index
aims
to
achieve
stronger
total
return
than
the
Russell
1000®
Value
Index
through
a
rules-based
strategic
beta
approach.
The
Index
methodology
leverages
the
results
of
Columbia
Threadneedle
Investment’s
proprietary
quantitative
investment
models
to
rate
each
company
within
the
Russell
1000®
Value
Index
based
on
quality,
value
and
catalyst
factors,
and
selects
securities
that
are
favorably
rated.
It
is
market
cap-weighted
and
sector-neutral
to
the
Russell
1000®
Value
Index.
The
Russell
1000®
Value
Index
is
an
unmanaged
index
that
measures
the
performance
of
those
Russell
1000®
Index
companies
with
lower
price-to-book
ratios
and
lower
forecasted
growth
values.
It
is
not
possible
to
invest
directly
in
an
index.
Indices
are
not
available
for
investment,
are
not
professionally
managed
and
do
not
reflect
sales
charges,
fees,
brokerage
commissions,
taxes
or
other
expenses
of
investing.
Securities
in
the
Fund
may
not
match
those
in
an
index.
Average
annual
total
returns
(%)
(for
period
ended
April
30,
2023)
Inception
6
Months
cumulative
1
Year
Life
Market
Price
09/25/19
4.97
1.88
9.04
Net
Asset
Value
09/25/19
5.34
2.04
9.12
{
Beta
Advantage
}
®
Research
Enhanced
U.S.
Value
Index
5.42
2.26
9.26
Russell
1000®
Value
Index
4.54
1.21
7.89
FUND
AT
A
GLANCE
(continued)
Columbia
Research
Enhanced
Value
ETF
(Unaudited)
6
Strategic
Beta
ETFs
|
Semiannual
Report
2023
Equity
sector
breakdown
(%)
(at
April
30,
2023)
Financials
20
.1
Health
Care
15
.4
Industrials
10
.4
Communication
Services
10
.2
Energy
8
.4
Consumer
Staples
7
.3
Information
Technology
7
.2
Consumer
Discretionary
6
.6
Utilities
5
.7
Materials
4
.5
Real
Estate
4
.2
Total
100
.0
Percentages
indicated
are
based
upon
total
equity
investments.
The
Fund’s
portfolio
composition
is
subject
to
change.
UNDERSTANDING
YOUR
FUND’S
EXPENSES
(Unaudited)
Strategic
Beta
ETFs
|
Semiannual
Report
2023
7
As
a
shareholder
of
a
Fund,
you
incur
ongoing
costs,
including
investment
management
fees.
The
following
example
is
intended
to
help
you
understand
your
ongoing
costs
(in
dollars
and
cents)
of
investing
in
a
fund
and
to
compare
these
costs
with
the
ongoing
costs
of
investing
in
other
funds.
The
examples
are
based
on
an
initial
investment
of
$1,000
invested
at
the
beginning
of
the
period
and
held
for
the
period
ended
April
30,
2023.
Actual
Expenses
The
information
under
each
column
in
the
table
below
entitled
“Actual”
provides
information
about
actual
account
values
and
actual
expenses.
You
may
use
the
information
in
these
columns,
together
with
the
amount
you
invested,
to
estimate
the
expenses
that
you
paid
over
the
period.
Simply
divide
your
account
value
by
$1,000
(for
example,
an
$8,600
account
value
divided
by
$1,000
=
8.6),
then
multiply
the
result
by
the
number
for
your
Fund
under
the
heading
entitled
“Expenses
paid
for
the
period”
to
estimate
the
expenses
you
paid
on
your
account
during
this
period.
Hypothetical
Example
For
Comparison
Purposes
The
information
under
each
column
in
the
table
entitled
“Hypothetical”
provides
information
about
hypothetical
account
values
and
hypothetical
expenses
based
on
each
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
The
hypothetical
account
values
and
expenses
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period.
You
may
use
this
information
to
compare
the
ongoing
costs
of
investing
in
your
Fund
and
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
the
other
funds.
Please
note
that
the
expenses
shown
in
the
table
are
meant
to
highlight
your
ongoing
costs
only
and
do
not
reflect
any
transactional
costs,
such
as
brokerage
commissions
paid
on
purchases
and
sales
of
Fund
shares.
Therefore,
the
ending
account
values
and
expenses
paid
for
the
period
in
the
table
is
useful
in
comparing
ongoing
Fund
costs
only
and
will
not
help
you
determine
the
relative
total
costs
of
owning
different
funds.
In
addition,
if
these
transactional
costs
were
included,
your
costs
would
have
been
higher.
Expenses
are
calculated
using
the
Fund’s
annualized
expense
ratio,
multiplied
by
the
average
account
value
over
the
period,
then
multiplied
by
the
number
of
days
in
the
Fund’s
most
recent
fiscal
half-year
and
divided
by
365.
Expenses
do
not
include
fees
and
expenses
incurred
indirectly
by
the
Fund
from
its
investment
in
underlying
funds,
including
affiliated
and
non-
affiliated
pooled
investment
vehicles,
such
as
mutual
funds
and
exchange-traded
funds.
November
1,
2022
April
30,
2023
Beginning
account
value
($)
Ending
account
value
($)
Expense
paid
for
the
period
($)
Annualized
expense
ratios
for
the
period
(%)
Actual
Hypothetical
Actual
Hypothetical
Actual
Hypothetical
Actual
Columbia
Research
Enhanced
Core
ETF
1,000.00
1,000.00
1,082.60
1,024.05
0.77
0.75
0.15
Columbia
Research
Enhanced
Value
ETF
1,000.00
1,000.00
1,053.40
1,023.85
0.97
0.95
0.19
PORTFOLIO
OF
INVESTMENTS
Columbia
Research
Enhanced
Core
ETF
April
30,
2023
(Unaudited)
(Percentages
represent
value
of
investments
compared
to
net
assets)
Investments
in
Securities
The
accompanying
Notes
to
the
Financial
Statements
are
an
integral
part
of
these
financial
statements.
8
Strategic
Beta
ETFs
|
Semiannual
Report
2023
Common
Stocks
99.4%
Issuer
Shares
Value
($)
Communication
Services  8.6%
Diversified
Telecommunication
Services
0.7%
Lumen
Technologies,
Inc.
6,002
14,225
Verizon
Communications,
Inc.
24,768
961,741
Total
975,966
Entertainment
0.2%
Electronic
Arts,
Inc.
1,640
208,739
Live
Nation
Entertainment,
Inc.
(a)
912
61,815
Playtika
Holding
Corp.
(a)
603
6,030
World
Wrestling
Entertainment,
Inc.
Class
A
257
27,543
Total
304,127
Interactive
Media
&
Services
7.4%
Alphabet,
Inc.
Class
A
(a)
36,083
3,873,149
Alphabet,
Inc.
Class
C
(a)
31,770
3,438,149
Meta
Platforms,
Inc.
Class
A
(a)
13,426
3,226,536
TripAdvisor,
Inc.
(a)
617
10,940
Total
10,548,774
Media
0.3%
Fox
Corp.
Class
A
1,730
57,540
Fox
Corp.
Class
B
831
25,379
Interpublic
Group
of
Cos.,
Inc.
(The)
2,339
83,573
New
York
Times
Co.
(The)
Class
A
959
38,120
News
Corp.
Class
A
2,305
40,591
News
Corp.
Class
B
720
12,780
Nexstar
Media
Group,
Inc.
222
38,506
Omnicom
Group,
Inc.
1,188
107,597
Total
404,086
Total
Communication
Services
12,232,953
Consumer
Discretionary  9.6%
Automobile
Components
0.2%
BorgWarner,
Inc.
4,742
228,232
Automobiles
0.1%
Harley-Davidson,
Inc.
2,726
101,135
Thor
Industries,
Inc.
1,009
79,731
Total
180,866
Broadline
Retail
0.6%
eBay,
Inc.
11,040
512,587
Etsy,
Inc.
(a)
2,689
271,670
Macy's,
Inc.
5,605
91,586
Nordstrom,
Inc.
2,257
34,893
Total
910,736
Distributors
0.5%
Genuine
Parts
Co.
2,824
475,307
LKQ
Corp.
5,150
297,310
Total
772,617
Diversified
Consumer
Services
0.3%
ADT,
Inc.
4,250
28,475
Grand
Canyon
Education,
Inc.
(a)
657
77,986
H&R
Block,
Inc.
3,130
106,139
Service
Corp.
International
3,091
216,957
Total
429,557
Hotels,
Restaurants
&
Leisure
1.7%
Aramark
4,673
162,153
Boyd
Gaming
Corp.
1,573
109,166
Darden
Restaurants,
Inc.
2,474
375,875
Expedia
Group,
Inc.
(a)
2,937
275,961
Hyatt
Hotels
Corp.
Class
A
(a)
968
110,642
Marriott
International,
Inc.
Class
A
5,466
925,613
Marriott
Vacations
Worldwide
Corp.
765
102,938
MGM
Resorts
International
6,590
296,023
Travel
+
Leisure
Co.
1,649
63,107
Total
2,421,478
Common
Stocks
(continued)
Issuer
Shares
Value
($)
Household
Durables
1.7%
DR
Horton,
Inc.
6,422
705,264
Lennar
Corp.
Class
A
5,069
571,834
Lennar
Corp.
Class
B
295
28,857
NVR,
Inc.
(a)
60
350,400
PulteGroup,
Inc.
4,654
312,516
Toll
Brothers,
Inc.
2,273
145,267
TopBuild
Corp.
(a)
650
146,562
Whirlpool
Corp.
1,083
151,176
Total
2,411,876
Specialty
Retail
4.3%
AutoNation,
Inc.
(a)
766
100,882
AutoZone,
Inc.
(a)
395
1,052,007
Bath
&
Body
Works,
Inc.
4,562
160,126
Best
Buy
Co.,
Inc.
4,023
299,794
Lowe's
Cos.,
Inc.
12,573
2,613,047
O'Reilly
Automotive,
Inc.
(a)
1,260
1,155,811
Penske
Automotive
Group,
Inc.
536
74,279
Ulta
Beauty,
Inc.
(a)
1,057
582,861
Victoria's
Secret
&
Co.
(a)
1,693
52,500
Total
6,091,307
Textiles,
Apparel
&
Luxury
Goods
0.2%
PVH
Corp.
1,349
115,758
Tapestry,
Inc.
4,976
203,070
Total
318,828
Total
Consumer
Discretionary
13,765,497
Consumer
Staples  7.2%
Beverages
1.2%
Coca-Cola
Co.
(The)
26,838
1,721,658
Consumer
Staples
Distribution
2.0%
Albertsons
Cos.,
Inc.
Class
A
1,600
33,440
Casey's
General
Stores,
Inc.
256
58,578
Dollar
General
Corp.
4,675
1,035,326
Kroger
Co.
(The)
4,559
221,704
Walmart,
Inc.
10,039
1,515,588
Total
2,864,636
Food
Products
1.0%
Archer-Daniels-Midland
Co.
3,822
298,422
Campbell
Soup
Co.
1,354
73,522
Conagra
Brands,
Inc.
3,240
122,990
Darling
Ingredients,
Inc.
(a)
1,080
64,336
General
Mills,
Inc.
4,097
363,117
JM
Smucker
Co.
(The)
704
108,705
Kellogg
Co.
1,734
120,981
Kraft
Heinz
Co.
(The)
4,770
187,318
Pilgrim's
Pride
Corp.
(a)
320
7,299
Tyson
Foods,
Inc.
Class
A
1,892
118,231
Total
1,464,921
Household
Products
1.8%
Procter
&
Gamble
Co.
(The)
16,301
2,549,150
Tobacco
1.2%
Altria
Group,
Inc.
12,359
587,176
Philip
Morris
International,
Inc.
10,534
1,053,084
Total
1,640,260
Total
Consumer
Staples
10,240,625
Energy  4.8%
Energy
Equipment
&
Services
0.0%
NOV,
Inc.
2,292
38,391
Oil,
Gas
&
Consumable
Fuels
4.8%
Antero
Resources
Corp.
(a)
1,573
36,163
Chesapeake
Energy
Corp.
670
55,396
Chevron
Corp.
11,268
1,899,560
PORTFOLIO
OF
INVESTMENTS
(continued)
Columbia
Research
Enhanced
Core
ETF
April
30,
2023
(Unaudited)
The
accompanying
Notes
to
the
Financial
Statements
are
an
integral
part
of
these
financial
statements.
Strategic
Beta
ETFs
|
Semiannual
Report
2023
9
Common
Stocks
(continued)
Issuer
Shares
Value
($)
ConocoPhillips
7,117
732,268
EQT
Corp.
2,049
71,387
Exxon
Mobil
Corp.
23,353
2,763,594
HF
Sinclair
Corp.
833
36,744
Marathon
Oil
Corp.
3,851
93,040
Marathon
Petroleum
Corp.
2,733
333,426
Occidental
Petroleum
Corp.
4,625
284,576
PDC
Energy,
Inc.
544
35,387
Phillips
66
2,717
268,983
Valero
Energy
Corp.
2,232
255,943
Vitesse
Energy,
Inc.
320
5,888
Total
6,872,355
Total
Energy
6,910,746
Financials  13.2%
Banks
2.9%
Bank
OZK
1,468
52,437
Citigroup,
Inc.
25,150
1,183,811
Citizens
Financial
Group,
Inc.
6,321
195,572
East
West
Bancorp,
Inc.
1,845
95,368
First
Citizens
BancShares,
Inc.
Class
A
166
167,192
Huntington
Bancshares,
Inc.
18,793
210,482
Popular,
Inc.
939
56,349
Webster
Financial
Corp.
2,288
85,342
Wells
Fargo
&
Co.
50,120
1,992,270
Wintrust
Financial
Corp.
789
53,944
Total
4,092,767
Capital
Markets
2.9%
Affiliated
Managers
Group,
Inc.
499
72,046
Bank
of
New
York
Mellon
Corp.
(The)
9,547
406,607
Cboe
Global
Markets,
Inc.
1,406
196,418
CME
Group,
Inc.
4,636
861,230
Invesco
Ltd.
4,906
84,040
Jefferies
Financial
Group,
Inc.
2,618
83,854
Lazard
Ltd.
Class
A
1,165
36,464
Morgan
Stanley
16,198
1,457,334
Nasdaq,
Inc.
4,557
252,321
Raymond
James
Financial,
Inc.
2,542
230,127
SEI
Investments
Co.
1,344
79,175
State
Street
Corp.
4,488
324,303
Total
4,083,919
Consumer
Finance
0.8%
Ally
Financial,
Inc.
3,985
105,124
Capital
One
Financial
Corp.
4,917
478,424
Discover
Financial
Services
3,474
359,455
SLM
Corp.
3,125
46,938
Synchrony
Financial
6,036
178,122
Total
1,168,063
Financial
Services
3.0%
Equitable
Holdings,
Inc.
4,985
129,560
Jack
Henry
&
Associates,
Inc.
370
60,436
Mastercard,
Inc.
Class
A
4,252
1,615,888
MGIC
Investment
Corp.
3,943
58,632
PayPal
Holdings,
Inc.
(a)
5,743
436,468
Visa,
Inc.
Class
A
7,994
1,860,444
Voya
Financial,
Inc.
1,289
98,583
WEX,
Inc.
(a)
218
38,662
Total
4,298,673
Insurance
3.5%
American
Financial
Group,
Inc.
894
109,721
American
International
Group,
Inc.
9,870
523,505
Aon
PLC
Class
A
2,754
895,546
Axis
Capital
Holdings
Ltd.
1,009
57,049
Common
Stocks
(continued)
Issuer
Shares
Value
($)
Brighthouse
Financial,
Inc.
(a)
934
41,283
CNA
Financial
Corp.
364
14,163
Everest
Re
Group
Ltd.
506
191,268
Hartford
Financial
Services
Group,
Inc.
(The)
4,213
299,081
Lincoln
National
Corp.
2,189
47,567
Loews
Corp.
2,566
147,725
Marsh
&
McLennan
Cos.,
Inc.
6,576
1,184,929
MetLife,
Inc.
8,923
547,247
Prudential
Financial,
Inc.
4,900
426,300
Reinsurance
Group
of
America,
Inc.
892
126,949
Unum
Group
2,636
111,239
Willis
Towers
Watson
PLC
1,430
331,188
Total
5,054,760
Mortgage
Real
Estate
Investment
Trusts
(REITs)
0.1%
Annaly
Capital
Management,
Inc.
5,575
111,388
Starwood
Property
Trust,
Inc.
3,810
68,161
Total
179,549
Total
Financials
18,877,731
Health
Care  13.4%
Biotechnology
2.4%
AbbVie,
Inc.
6,652
1,005,250
Alnylam
Pharmaceuticals,
Inc.
(a)
459
91,433
Amgen,
Inc.
2,026
485,713
Biogen,
Inc.
(a)
540
164,284
BioMarin
Pharmaceutical,
Inc.
(a)
695
66,748
Exact
Sciences
Corp.
(a)
667
42,735
Exelixis,
Inc.
(a)
1,231
22,527
Gilead
Sciences,
Inc.
4,711
387,291
Horizon
Therapeutics
PLC
(a)
833
92,596
Incyte
Corp.
(a)
688
51,194
Ionis
Pharmaceuticals,
Inc.
(a)
524
18,534
Mirati
Therapeutics,
Inc.
(a)
171
7,577
Moderna,
Inc.
(a)
1,306
173,554
Natera,
Inc.
(a)
369
18,716
Neurocrine
Biosciences,
Inc.
(a)
370
37,385
Novavax,
Inc.
(a)
325
2,493
Regeneron
Pharmaceuticals,
Inc.
(a)
396
317,509
Sarepta
Therapeutics,
Inc.
(a)
307
37,691
Seagen,
Inc.
(a)
504
100,800
Ultragenyx
Pharmaceutical,
Inc.
(a)
249
10,874
United
Therapeutics
Corp.
(a)
169
38,892
Vertex
Pharmaceuticals,
Inc.
(a)
969
330,167
Total
3,503,963
Health
Care
Equipment
&
Supplies
1.1%
Abbott
Laboratories
10,663
1,177,942
DENTSPLY
SIRONA,
Inc.
1,343
56,312
Enovis
Corp.
(a)
312
18,174
Hologic,
Inc.
(a)
1,542
132,627
Integra
LifeSciences
Holdings
Corp.
(a)
458
25,337
Zimmer
Biomet
Holdings,
Inc.
1,330
184,125
Total
1,594,517
Health
Care
Providers
&
Services
4.3%
AmerisourceBergen
Corp.
1,058
176,527
Cardinal
Health,
Inc.
1,735
142,444
Centene
Corp.
(a)
3,436
236,844
Cigna
Group
(The)
1,841
466,307
CVS
Health
Corp.
8,097
593,591
Elevance
Health,
Inc.
1,526
715,160
Humana,
Inc.
803
425,983
McKesson
Corp.
902
328,544
Molina
Healthcare,
Inc.
(a)
364
108,432
PORTFOLIO
OF
INVESTMENTS
(continued)
Columbia
Research
Enhanced
Core
ETF
April
30,
2023
(Unaudited)
The
accompanying
Notes
to
the
Financial
Statements
are
an
integral
part
of
these
financial
statements.
10
Strategic
Beta
ETFs
|
Semiannual
Report
2023